×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 1006 Generic Drug Forum - II - Product Development for Quality Consistency
Session Chair(s)
Yi REN, PhD, MBA
General Manager
Nanjing Medichem Bio-Pharmaceutical Development Co. , China
Jane Y. Cai, PhD
Former Managing Director
DIA China, China
Speaker(s)
Generic reevaluation DIA meeting (EN&CN)
Xinsheng Sun
China Quality Association for Pharmaceuticals(CQAP), China
Director
1006-2_BingLi_Scientific and Regulatory Considerations for Establishing Bioequivalence of Generic Drug Products in USA (EN&CN).pdf
Bing V. Li
FDA, United States
Pharmacologist
Considerations for OTC Development For Emerging Markets (EN&CN)
Chao Ye, PhD
Johnson & Johnson China, China
Associate Director, Research and Development, OTC
Have an account?